Zhou et al’s study found that GP73 induced cisplatin resistance in HT29 colon cancer cells was related to the activation of the mitogen-activated protein kinase/ERK and Wnt/β-catenin signaling pathways [21]. This evidence concerns the gene GOLM1 and malignant colon neoplasm.